- Home
- MNKD vs STEW Comparison
MNKD vs STEW Comparison
Compare MNKD & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- STEW
- Stock Information
- Founded
- MNKD 1991
- STEW 1972
- Country
- MNKD United States
- STEW United States
- Employees
- MNKD N/A
- STEW N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- STEW Investment Managers
- Sector
- MNKD Health Care
- STEW Finance
- Exchange
- MNKD Nasdaq
- STEW Nasdaq
- Market Cap
- MNKD 1.4B
- STEW 1.6B
- IPO Year
- MNKD 2004
- STEW N/A
- Fundamental
- Price
- MNKD $4.56
- STEW $17.35
- Analyst Decision
- MNKD Buy
- STEW
- Analyst Count
- MNKD 6
- STEW 0
- Target Price
- MNKD $8.92
- STEW N/A
- AVG Volume (30 Days)
- MNKD 1.5M
- STEW 84.5K
- Earning Date
- MNKD 05-08-2025
- STEW 01-01-0001
- Dividend Yield
- MNKD N/A
- STEW 3.71%
- EPS Growth
- MNKD 215.86
- STEW N/A
- EPS
- MNKD 0.10
- STEW 1.44
- Revenue
- MNKD $297,595,000.00
- STEW N/A
- Revenue This Year
- MNKD $14.23
- STEW N/A
- Revenue Next Year
- MNKD $14.56
- STEW N/A
- P/E Ratio
- MNKD $46.04
- STEW $10.34
- Revenue Growth
- MNKD 32.50
- STEW N/A
- 52 Week Low
- MNKD $4.17
- STEW $11.97
- 52 Week High
- MNKD $7.63
- STEW $14.94
- Technical
- Relative Strength Index (RSI)
- MNKD 38.80
- STEW 58.96
- Support Level
- MNKD $4.42
- STEW $16.76
- Resistance Level
- MNKD $5.05
- STEW $17.59
- Average True Range (ATR)
- MNKD 0.18
- STEW 0.26
- MACD
- MNKD 0.00
- STEW 0.04
- Stochastic Oscillator
- MNKD 20.59
- STEW 80.24
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.